Segesterone acetate and ethinyl estradiol vaginal system

(Annovera)

Segesterone acetate and ethinyl estradiol vaginal system

Drug updated on 11/16/2023

Dosage FormVaginal ring (intravaginal; 103 mg segesterone acetate and 17.4 mg ethinyl estradiol)
Drug ClassCombination hormonal contraceptives
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • Indicated for use by females of reproductive potential to prevent pregnancy.

Product Monograph / Prescribing Information

Document TitleYearSource
Annovera (segesterone acetate and ethinyl estradiol vaginal system) Prescribing Information.2022TherapeuticsMD, Inc., Boca Raton, FL

Systematic Reviews / Meta-Analyses